RMTI — ROCKWELL MEDICAL, INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1041024 ·
Last close
$0.76
Market Cap
$29.82M
52W High
$1.09
52W Low
$0.74
ADV30
266,205
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 17,336,000 | 2,897,000 | -1,480,000 | -1,605,000 | 57,423,000 | 9,609,000 | 21,566,000 |
| Dec 2025 | 18,346,000 | 3,878,000 | -398,000 | -554,000 | 57,145,000 | 10,711,000 | 20,164,000 |
| Sep 2025 | 15,927,000 | 2,272,000 | -1,584,000 | -1,753,000 | 57,486,000 | 13,610,000 | 20,466,000 |
| Jun 2025 | 16,071,000 | 2,503,000 | -1,349,000 | -1,492,000 | 52,625,000 | 12,482,000 | 22,216,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-659,000
Investing CF
$-8,544,000
Financing CF
$4,252,000
CapEx
$-542,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.15
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-402,992,000
Inventory
$3,424,000
Receivables
$8,143,000
ST Investments
$14,286,000
EBIT TTM
$-4,190,000
Pretax Income TTM
$-5,314,000
Interest Exp TTM
$1,124,000
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$67,680,000
EBITDA
$-2,610,000
Free Cash Flow
—
Enterprise Value
—
Total Cash
—
Total Debt
—
Shares Out
39,470,299
Trailing EPS
$-0.15
Book Value
$0.94
ROE
—
ROA
—
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 69,258,000 | -4,691,000 | -5,314,000 | 57,145,000 | 20,164,000 | — | -659,000 |
| Dec 2024 | 101,489,000 | 608,000 | -480,000 | 59,208,000 | 26,622,000 | — | 4,202,000 |
| Dec 2023 | 83,612,000 | -6,670,000 | -8,439,000 | 52,173,000 | 30,882,000 | — | -9,412,000 |
| Dec 2022 | 72,810,000 | -16,780,000 | -18,679,000 | 46,635,000 | 32,529,000 | — | -16,929,000 |
TTM Snapshot
Revenues TTM
$25,832,000
NetIncome TTM
$343,000
OpCashFlow TTM
$0
Assets (Latest)
$59,208,000
Forward EPS
$0.07
Max Pain — expiry 2026-08-21 (volume-derived — Yahoo OI feed degraded)
max pain strike: $0.50 · spot: $0.76 · call volume: 4 · put volume: 6
Expected Move to 2026-08-21:
±$0.49
(64.47%) —
implied range
$0.27 –
$1.25
· ATM straddle on $1.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NEUP | Neuphoria Therapeutics Inc. | $29.52M | $5.46 | — |
| LSTA | LISATA THERAPEUTICS, INC. | $29.14M | $3.20 | — |
| PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | $28.96M | $0.07 | — |
| SKYE | Skye Bioscience, Inc. | $28.89M | $0.82 | — |
| CPHI | CHINA PHARMA HOLDINGS, INC. | $30.80M | $0.76 | — |
News headlines (Yahoo Finance, 1h cache)
Rockwell Medical Renews Product Purchase Agreement with aQua Dialysis
2026-05-20 10:00 · Yahoo
Rockwell Medical Signs New 3-Year Product Purchase Agreement with Heritage Dialysis
2026-05-14 10:00 · Yahoo
RMTI Q1 2026 Earnings Transcript
2026-05-08 15:11 · Yahoo
Rockwell Medical, Inc. Q1 2026 Earnings Call Summary
2026-05-08 12:30 · Yahoo
Rockwell Medical (RMTI) Reports Q1 Loss, Misses Revenue Estimates
2026-05-07 11:10 · Yahoo
Rockwell Medical Announces First Quarter 2026 Results and Additional 2026 Guidance with Focus on Profitability
2026-05-07 10:00 · Yahoo
How The Rockwell Medical (RMTI) Story Is Shifting With Recalibrated Fair Value Targets
2026-04-28 17:04 · Yahoo
Rockwell Medical to Release First Quarter 2026 Results on Thursday, May 7, 2026
2026-04-09 10:00 · Yahoo
Should Value Investors Buy Rockwell Medical (RMTI) Stock?
2026-03-27 13:40 · Yahoo
Fast-paced Momentum Stock Rockwell Medical (RMTI) Is Still Trading at a Bargain
2026-03-27 12:55 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.